Of note, SRC activity correlates with IL8 production in human L3.6pl and PANC-1 pancreatic cancer cell lines, while pharmacologic inhibition of endogenous SRC or siRNA-mediated knock-down of SRC significantly reduces IL8 production and angiogenesis [56]. Here, SRC is linked to pancreatic neoplasm.